Spectral Med Stock Performance
| EDTXF Stock | USD 0.61 0.02 3.39% |
Spectral Med has a performance score of 4 on a scale of 0 to 100. The entity has a beta of 0.11, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Spectral Med's returns are expected to increase less than the market. However, during the bear market, the loss of holding Spectral Med is expected to be smaller as well. Spectral Med right now has a risk of 2.56%. Please validate Spectral Med jensen alpha and the relationship between the value at risk and day median price , to decide if Spectral Med will be following its existing price patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Spectral Med are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Spectral Med may actually be approaching a critical reversion point that can send shares even higher in August 2025. ...more
| Begin Period Cash Flow | 5.8 M | |
| Total Cashflows From Investing Activities | -325 K |
Spectral |
Spectral Med Relative Risk vs. Return Landscape
If you would invest 57.00 in Spectral Med on April 28, 2025 and sell it today you would earn a total of 4.00 from holding Spectral Med or generate 7.02% return on investment over 90 days. Spectral Med is currently producing 0.1394% returns and takes up 2.5564% volatility of returns over 90 trading days. Put another way, 22% of traded pink sheets are less volatile than Spectral, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Spectral Med Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spectral Med's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Spectral Med, and traders can use it to determine the average amount a Spectral Med's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0545
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | EDTXF | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.56 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Spectral Med is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spectral Med by adding it to a well-diversified portfolio.
Spectral Med Fundamentals Growth
Spectral Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Spectral Med, and Spectral Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spectral Pink Sheet performance.
| Return On Equity | -7.84 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (6.38) % | |||
| Current Valuation | 65.99 M | |||
| Shares Outstanding | 278.22 M | |||
| Price To Earning | (13.69) X | |||
| Price To Book | 51.73 X | |||
| Price To Sales | 42.75 X | |||
| Revenue | 2.05 M | |||
| EBITDA | (8.46 M) | |||
| Cash And Equivalents | 3.47 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 537 K | |||
| Debt To Equity | 0.26 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (8.7 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 11.55 M | |||
| Retained Earnings | (51.99 M) | |||
| Current Asset | 6.33 M | |||
| Current Liabilities | 1.96 M | |||
About Spectral Med Performance
By analyzing Spectral Med's fundamental ratios, stakeholders can gain valuable insights into Spectral Med's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Spectral Med has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Spectral Med has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 31 people.Things to note about Spectral Med performance evaluation
Checking the ongoing alerts about Spectral Med for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Spectral Med help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spectral Med has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 2.05 M. Net Loss for the year was (8.79 M) with profit before overhead, payroll, taxes, and interest of 1.22 M. | |
| Spectral Med has accumulated about 3.47 M in cash with (8.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 20.0% of the company shares are held by company insiders |
- Analyzing Spectral Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spectral Med's stock is overvalued or undervalued compared to its peers.
- Examining Spectral Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spectral Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spectral Med's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spectral Med's pink sheet. These opinions can provide insight into Spectral Med's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Spectral Pink Sheet analysis
When running Spectral Med's price analysis, check to measure Spectral Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectral Med is operating at the current time. Most of Spectral Med's value examination focuses on studying past and present price action to predict the probability of Spectral Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectral Med's price. Additionally, you may evaluate how the addition of Spectral Med to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |